Our purpose was to study maternal blood and amniotic fluid concentrations of homocysteine and relevant vitamins in relation to neural tube defects, STUDY DESIGN; Concentrations of total homocysteine, folate, and vitamins B 12 and Be were measured in maternal blood and amniotic fluid of 27 women carrying a fetus with a neural tube defect and 31 control women carrying a healthy fetus, RESULTS: The mean total homocysteine concentration in amniotic fluid of the study group was significantly higher than that of the control group. The mean concentrations of total homocysteine In blood and the vitamins folate, B 12, and Be in, respectively, blood and amniotic fluid were not significantly different between the groups. The mean concentrations of homocysteine and vitamin B6 were significantly lower in amniotic fluid than in blood in both groups, whereas vitamin B12 in amniotic fluid was higher than in blood. CONCLUSION: These results support the hypothesis that at least the cause of a subset of neural tube defects could reside in a primary or secondary maternal or fetal derangement of homocysteine metabolism. (Am J O b s t e t G y n e c o l 1995;172:1436-41.) 
Decreased levels of folate and vitamin B.,, in m aternal blood have been associated with the pathogenesis of neural tube defects.1, a Periconceptional folate treat m ent of the m other is very likely to prevent neural tube defects/* 5 Recently we reported an association between a history o f offspring with a neural tube defect and m aternal mild hyperhom ocysteinem ia in the lasting state and after m ethionine loading.5, B However, it is unclear what biochemical mechanism is involved, but probably the underlying defect is located in the remethylation pathway of homocysteine metabolism.
5-M ethyltetrahydrofolate and B ]L, as methylcobalam in are involved in the rem ethylation of homocysteine to methionine. Vitamin B0 as pyridoxal phosphate is involved in the com peting transsulfuration pathway, which degrades hom ocysteine by cystathionine into cys teine. M alnutrition or a deranged metabolism of folate or vitamin B 12 im pairs the rem ethylation to m ethionine and results in hyperhom ocysteinem ia.7'9 T he m ost fre-quently encountered inherited enzymatic defects in ho mocysteine metabolism are deficiencies of the enzymes cystathionine synthase and 5,10-methylenetetrahydrofolate reductase." Noteworthy is the recently reported decreased enzyme activity o f a thermolabile form of 5,10-m ethylenetetrahydvofolate reductase, which may result in mild hyperhomocysteinemia in 5% of the general p o p u latio n .10 Increased homocysteine blood levels can be efficiently lowered by high-dose folate or vitamin B(i.u * In view of the previously reported association of m aternal hyperhom ocysteinem ia and offspring with a neural tube defect;, it would be intriguing to study the homocysteine exposure of the conceptus during the period that neural tube defects develop (i.e., third to fourth week after conception). However, it is not fea sible to assess the hom ocysteine concentrations in the yolk sac, in the neural tissue, or even in amniotic fluid during that early stage of hum an pregnancy. Therefore we studied both m aternal blood and mid trimester am niotic fluid concentrations o f total homocysteine, folate, and vitamins B la and Br> in women carrying a fetus with a neural tube defect and in a control group o f women carrying a norm al, healthy fetus.
Material and methods
Fifty-eight women were investigated after written in formed consent; was obtained. Exclusion criteria were gastrointestinal and endocrine disorders, dietary re- ) as concluded from a-fetoprotein determ inations in am niotic fluid and from ultrasonographic exam ination and confirmed by the pregnancy outcom e. T h e control group (group two) consisted of 31 wom en in whom amniocentesis was perform ed because of high m aternal age (30 to 40 years). All control women gave birth to a healthy child. All pregnancies were accurately dated by the last m enstrual period and by first-trim ester ultraso nographic investigation. T h e characteristics of both groups are presented in T able I.
Venous blood sam ples for the determ ination of plasma total hom ocysteine, serutn and red blood cell folate, serum vitam in B^, and whole blood vitamin Bn as pyridoxal p h o sp h ate were taken within 10 m inutes after amniocentesis. Amniotic fluid sam ples were ob tained by routine transabdom inal amniocentesis and collected in dry tubes o f 10 ml. All amniotic fluid samples were free from blood contam ination. T he samples were im m ediately centrifuged for 10 m inutes at. 3000 g, stored at -2 0° C, and assayed wit 1 iin 3 m onths after collection. T h e analytic m ethods used in the de term ination of vitamins in blood and amniotic fluid have been reported b efo re.1 ,4 Total homocysteine was determ ined essentially according to Fiskerstrand et al.H Results are expressed as m ean (SD), To obtain n o r mality, blood and am nion param eters were log-trans form ed. Possible differences between the groups were then evaluated with Welch's I test, whereas differences between paired observations were validated with the S tudent / test. Pearson's partial correlation coellicients (with the group effect partialed out) were calculated to study the relationship between the various variables. A p value < 0.05 was considered statistically significant.
Results
Amniocentesis was perform ed at a significantly more advanced gestational age in group 1 com pared with g roup 2, and the wom en in group 2 were significantly older than those in group 1 (Table I) .
T h e m ean concentrations of total homocysteine, folate, and vitamins and B(i in m aternal blood and am niotic fluid as found in groups I and 2 are given in T able II. T h e m ean amniotic fluid concentration of total hom ocysteine in group 1 was significantly higher than that of group 2 (p < 0.01), whereas these concen- culated between total homocysteine, the various vitamin levels, and m aternal and gestational age. Because the correlations appeared not to be significantly di fie rent between the groups and regression lines were parallel, congelation coefficients were calculated for both groups combined. T he correlations are shown in Table III and Fig. 2 . T he total homocysteine concentrations in plasma and amniotic fluid were not significantly corre lated with maternal age. Only plasma, not amniotic fluid total homocysteine concentrations, showed a sig nificant inverse correlation with gestational age, Folate levels in maternal serum and red blood cells were significantly inversely correlated with total homocys teine in amniotic fluid. Also, vitamin B lt, in amniotic fluid and maternal plasma homocysteine levels did show a significant inverse correlation.
Comment
This study dem onstrates that pregnant women carry ing a fetus with a neural tube defect (group 1) have significantly higher total homocysteine levels in am ni otic fluid than do controls (group 2). However, plasma total homocysteine levels did not differ significantly between groups, Plasma levels of either group were lower than those of* nonpregnant women (7.2 |imol/L in pregnant control women vs 0.8 (xmol/L in non pregnant women'1 ), which is in accordance with other studics.,' r,, 1 ,1 This finding might be related to hcmodilution, in creased remethylation of homocysteine induced by e n hanced dem ands for m ethionine by the fetus or to the 4 im pact o f increased sex horm one levels during preg nancy on hom ocysteine m etabolism .17, ,H T h e total hom ocysteine concentrations in amniotic fluid of both groups were significantly lower in amniotic fluid than in plasma, as has been demonstrated previ ously in norm al p regnancies.1* In the current study a significant positive correlation could be established b e tween the total hom ocysteine concentrations in the two com partm ents (i.e., m aternal plasma and amniotic fluid). T h e transplacental transfer of homocysteine may be an important; determ inant o f the level of homocys teine in am niotic fluid. T h e report of Kurc/ynski et al.,M I who first described an untreated homoeystimiric p reg nant woman with dramatically increased homocysteine concentration in am niotic fluid, is in accordance with this observation, However, it is not excluded that the increased hom ocysteine concentration in amniotic fluid is caused by a defective homocysteine metabolism or by leakage from tine neural tube defect of the Ictus into the amniotic fluid.
'There was no significant; correlation between total hom ocysteine in plasma or amniotic fluid and gesta tional or m aternal age, with the exception of the inverse correlation betw een plasm a total homocysteine and gestational age. Furtherm ore, it revealed from the study of Andersson et al.*0 chat total plasma homocysteine is directly correlated with age. T herefore it is very unlikely that the significantly higher total homocysteine levels in Muy 1995 Am J Obstet Gynccul amniotic fluid of fetuses with a neural tube defect compared with healthy controls are a consequence of the higher gestational age or the lower maternal age at which amniocentesis took place for the study group, Shojania"1 reported a progressive decline of serum and red blood cell folate and serum vitamin B ,2 con centrations in pregnancy and hypothesized that this might be caused by increased fetal demands, blood volume expansion, and increased urinary excretion and by changes in m aternal folate absorption and m etabo lism. In particular, changes in vitamin B 12 binders may contribute to the physiologic decrease of this vitamin in pregnancy.*1 Decreased blood levels o f vitamin B(i dur-
ing pregnancy have also been described.*'" Folate or vitamin B 12 deficiency results in increased homocysteine concentrations in blood and urine.8, u A significantly negative correlation between plasma total homocysteine and serum and red blood cell folate was observed in this study, which is consistent with previous studies.0, 11 T he m ean folate concentrations in m ater nal serum and red blood cells and amniotic fluid of group 1 were n ot significantly different from those in group 2. T herefore the increased homocysteine levels in amniotic fluid of group 1 cannot solely be explained on the basis of lower folate concentrations.
Also serum vitamin B 12 concentrations were com pa rable in the neural tube defect group and control women and were revealed to be within the norm al ranges as given earlier for w om en of com parable age.IiV ** In both groups vitamin B 12 concentrations in amniotic fluid were significantly higher than those in serum. This is in line with the results of previous studies suggesting that there is an active transplacental transfer of this vitamin against a concentration gradient.
Lower vitamin B 12 levels in amniotic fluid of normal pregnancies in wom en who previously had an infant with a neural lube defect have been determ ined in relation to increased am niotic fluid transcobalamin lev els."1 , This p h en o m en o n is thought to be an indica tion of a genetic factor in the predisposition of neural tube delects. However, in our study the mean vitamin B 12 concentration in am niotic fluid was not significantly lower in the neural tube defect group compared with the control group, To our knowledge, the presence of vitamin B0 in human amniotic fluid has not been dem onstrated be fore. In both groups the vitam in B0 levels were signifi cantly lower than in m aternal blood. Its mean concen trations in m aternal blood and amniotic fluid of the neural tube defect group were similar to the corre sponding values of controls. N o significant correlation between the concentrations of total homocysteine and vitamin B(} in blood or am niotic fluid was found.
In conclusion, a significantly higher mean total ho mocysteine concentration was observed in amniotic fluid of a pregnancy in which the fetus was affected with a neural tube defect compared with a control group. This might be the result of a primary or secondary derangement in maternal or fetal homocysteine me tabolism, which is in line with our findings and earlier findings of others;r,t li' "li We thank the participants who volunteered for this study. We also thank the prenatal diagnosis team in Nijmegen, Mrs. Y. Lawson, R. Fliervoet, and P. Hamel for practical assistance. We thank Mr. M. 
